Skip to content
DataLookout
Menu

NCT03964480

Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved 1 year 5 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 3 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Jul 30, 2025 to Dec 30, 2026 Show 6 more changesShow less
    • Enrollment increased: 1000 → 1500 participants
    • Eligibility criteria expanded, about 27 words
    • Study completion pushed from Jul 30, 2025 to Dec 30, 2027
    • Study description revised
    • Site details revised at 1 of 6 sites
    • Publications: details revised at 44 of 46 entries
  2. Notable Primary completion date: Jan 30, 2023 to Jul 30, 2025
    • Site contacts updated at 1 of 6 sites
    v3
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Progression-free survival (PFS)
Timeframe: 2 year

Secondary (4)

Overall Survival (OS)
Progression-Free Survival (PFS)
Event Free Survival (EFS)
Complete Response Rate (CR)

Sites

6 sites in 4 countries

Italy 3, Romania 1, Ukraine 1, United States 1